Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04488003
Status:
TERMINATED
Last Update Posted:
2024-06-04
First Post:
2020-07-17
Brief Title:
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations
Sponsor:
BioMed Valley Discoveries Inc
Organization:
BioMed Valley Discoveries Inc
Organization Data
Organization:
BioMed Valley Discoveries Inc
Class:
INDUSTRY
Study ID:
BVD-523-ABC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMed Valley Discoveries Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None